Education
About Us
Working with TipRanks
Follow Us
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -4.13K | $ -11.76K | $ -13.07K | $ -11.10K |
| Operating Income | $ -14.90M | $ -18.87M | $ -15.27M | $ -14.03M | $ -9.45M |
| EBITDA | $ -14.90M | $ -18.86M | $ -15.26M | $ -14.47M | $ -9.44M |
| Net Income | $ -14.86M | $ -18.85M | $ -15.27M | $ -14.50M | $ -9.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.46M | $ 548.72K | $ 10.06M | $ 5.00M | $ 14.04M |
| Total Assets | $ 8.70M | $ 1.70M | $ 13.05M | $ 8.76M | $ 15.85M |
| Total Debt | $ 326.07K | $ 300.81K | $ 409.97K | $ 387.79K | $ 439.29K |
| Net Debt | $ -6.14M | $ -247.91K | $ -9.65M | $ -4.62M | $ -13.60M |
| Total Liabilities | $ 2.52M | $ 6.13M | $ 4.92M | $ 2.14M | $ 1.91M |
| Stockholders' Equity | $ 6.18M | $ -4.43M | $ 8.13M | $ 6.62M | $ 13.95M |
| Cash Flow | |||||
| Free Cash Flow | $ -17.12M | $ -14.14M | $ -10.56M | $ -13.54M | $ -7.34M |
| Operating Cash Flow | $ -17.11M | $ -14.14M | $ -10.56M | $ -13.54M | $ -7.32M |
| Investing Cash Flow | $ -4.19K | $ -3.90K | $ -4.42K | $ -5.75K | $ -17.95K |
| Financing Cash Flow | $ 23.03M | $ 4.64M | $ 15.61M | $ 4.51M | $ 14.13M |